Dr. Mansukh Mandaviya, Union Health Minister, stated on Wednesday that the vaccinations available in India are effective against Omicron Sub-variant BF.7. “We discovered the BF.7 variant in a few travellers. Our vaccine, on the other hand, is effective against the BF.7 strain. We’re taking all essential precautions “Mandaviya made the remarks at the presentation of a book titled Braving A Viral Storm: India’s Covid-19 Vaccine Story. He stated that, given the global spread of the Covid fourth wave, 8,700 flights have been identified thus far.
On Wednesday, India recorded 171 new COVID-19 cases in the previous 24 hours, according to the Ministry of Health and Family Welfare. The country’s active caseload now stands at 2,342. According to the health ministry, 4,41,47,322 persons have recovered since the epidemic began, with 148 recoveries occurring in the previous 24 hours.
Active cases account for 0.01 percent of all infections, with a recovery rate of 98.8 percent. According to the ministry, the daily positivity rate was 0.09 percent and the weekly positivity rate was 0.11 percent. In the previous 24 hours, the country conducted 1,80,926 tests, for a total of 91.25 crore tests.
“The sewage sampling is being done and there also we are not getting any indication that either a new variant is here or there is a possibility of the upsurge of cases in the coming days or weeks,” Chairman of COVID-19 working group NTAGI, Dr NK Arora said.
The official said that India has maintained to be in a “reasonably comfortable position” during the last 12 months.
“Our genomic surveillance system has identified almost 300 plus sub-variants of Omicron and they are spread all over the place. From time to time a certain sub-lineage becomes dominant. But the important point is that throughout the years we did not have any massive increase or surge in hospitalizations or deaths,” he said.
On Monday Union Health Ministry also said, “Sentinel sequencing of 324 COVID Positive Samples reveals the presence of all Omicron Variants in the Community. No mortality or rise in transmission was reported in areas where these variants were detected”.
